Lean body mass only anthropometric risk factor for atrial fibrillation
Compared to 8 other anthropometric risk factors, lean body mass was the predominant and independent anthropometric driver for AF risk.
Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial FibrillationLiterature - Fenger-Grøn M, Overvad K, Tjønneland A and Frost L. - JACC 2017; 69(20):2488-2497
Background
As the incidence of atrial fibrillation (AF) increases and it is associated with many adverse effects and human and health-economic costs, identification of modifiable risk factors is high desired [1-5]. Although obesity is frequently emphasized as being one of the modifiable risk factors, this association may be largely due to correlations between weight, BMI, waist and hip circumference, waist-to-hip ratio, fat mass, fat percentage, height and lean body mass [6,7].
In the present study, data from the Danish Diet, Cancer and Health cohort was updated (n=55 273) to depict correlations between the 9 above mentioned anthropometric measures and to assess their associations with risk of AF or atrial flutter under mutual adjustment. Median follow-up was 16.9 years.
Main results
- 1473 women and 2395 men developed AF, with a median time to event of 11.5 years.
- Almost all 9 anthropometric measures were positively correlated with each other, generally with Pearson’s R >0.6 in both sexes.
- Also, all 9 measures highly significantly positively associated with risk of AF (HR lean body mass 1.37, 95% CI 1.33-1.42, fat mass HR 1.25, 95% CI 1.22-1.29, fat % HR 1.16, 95% CI 1.12-1.20, HR height 1.29, 95% CI 1.24-1.33, HR weight 1.33, 95% CI 1.29-1.36, HR BMI 1.22, 95% CI 1.18-1.26, HR hip circumference 1.26, 95% CI 1.22-1.30, HR waist circumference 1.24, 95% CI 1.20-1.28, HR waist-to-hip ratio 1.08, 95% CI 1.05-1.12, all P<0.0001).
- All HRs adjusted for each other ranged from 1.08 (95% CI 1.05-1.12) to 1.37 (95% CI 1.33 to 1.42), however when also adjusted for lean body mass, almost none of the associations were significant anymore: HR fat mass 1.02 (95% CI 0.98-1.06, P=0.35, fat % 1.01 (95% CI 0.98-1.05, P-0.52), height 1.05 (95% CI 1.01-1.10, P=0.03), weight 1.03 (95% CI 0.97-1.09, P=0.38), BMI 1.00 (95% CI 0.96-1.04, P=0.97), hip circumference 1.02 (95% CI 0.98-1.04, P=0.98), waist-to-hip ratio 0.99 (95% CI 0.95-1.02, P=0.47).
- On the other hand, the association for lean body mass remained almost unchanged when adjusted for any of the 9 other measures: HR 1.36 (95% CI 1.30-1.41) corrected for fat mass, 1.37 (95% CI 1.32-1.41) corrected for fat%, 1.33 (95% CI 1.28-1.39) corrected for height, 1.34 (95% CI 1.26-1.43) corrected for weight, 1.38 (95% CI 1.32-1.43) corrected for BMI, 1.35 (95% CI 1.30-1.41) corrected for hip circumference, 1.37 (95% CI 1.32-1.43) corrected for waist circumference and 1.38 (95% CI 1.34-1.42) corrected for waist-to-hip ratio, all P<0.0001.
- The observed incidence rates for AF for both sexes developed slightly differently with age, but the estimated association for lean body mass corrected this difference in risk levels below the age of 70.
Conclusion
All 9 anthropometric measures height, weight, BMI, hip and waist circumference, waist-to-hip ratio and bioimpedance-derived fat mass, lean body mass and fat percentage were, as expected, positively associated with AF risk, however correlations between measures were also present. After multiple correction, lean body mass was the predominant anthropometric driver for AF risk, whereas none of the traditional obesity-related measures proved to have any independent influence. This questions the role played by fat in the AF etiology.
References
1. Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an
evolving epidemic in the 21st century. Int J Cardiol 2013;167:1807–24.
2. 6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the
Framingham Study. Stroke 1991;22:983–8.
3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial
fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946–52.
4. Wu EQ, Birnbaum HG, Mareva M, et al. Economic burden and co-morbidities of atrial fibrillation
in a privately insured population. Curr Med Res Opin 2005;21:1693–9.
5. Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence,
risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386:
154–62.
6. Lee JJ, Yin X, Hoffmann U, Fox CS, Benjamin EJ. Relation of pericardial fat, intrathoracic
fat, and abdominal visceral fat with incident atrial fibrillation (from the Framingham Heart
Study). Am J Cardiol 2016;118:1486–92.
7. Nalliah CJ, Sanders P, Kottkamp H, Kalman JM. The role of obesity in atrial fibrillation. Eur Heart J
2016;37:1565–72.